Investors reposed faith in our future growth prospects: Syngene
Readying to list its shares after a bumper 32-times over-subscribed IPO, biotechnology major Biocon's research arm Syngene on Thursday said the investors have reposed faith in its future growth prospects.
Jul 30, 2015, 16:51 PM IST
Biocon sets price band at Rs 240-250 for research arm's IPO
Biotechnology major Biocon Ltd has set the price band at Rs 240-250 per equity share for the initial public offering of its research arm Syngene International Ltd.
Jul 16, 2015, 09:10 AM IST
Biocon files prospectus for Syngene IPO to raise Rs 600 cr
Biotechnology major Biocon Wednesday filed prospectus with market regulator SEBI for the initial public offer of its research arm Syngene through which aims to raise around Rs 600 crore that will be used to fund its R&D programmes.
Apr 22, 2015, 20:00 PM IST
Biocon to file for Syngene unit's IPO in two months: Sources
Biotechnology firm Biocon Ltd could file a prospectus for a share listing for its research services business arm Syngene International within the next two months, two sources directly involved in the process said.
Mar 31, 2015, 17:54 PM IST
